Mesenchymal Stem Cells Improve Heart Rate Variability and Baroreflex Sensitivity in Rats with Chronic Heart Failure

Stem Cells and Development

Volumn 24, Issue 18, 2015, Pages 2181-2192

  De Morais, Sharon Del Bem Velloso ^a   Da Silva, Luiz Eduardo Virgilio ^a   Lataro, Renata Maria ^a   Silva, Carlos Alberto Aguiar ^a   De Oliveira, Luciano Fonseca Lemos ^a   De Carvalho, Eduardo Elias Vieira ^a   Simões, Marcus Vinicius ^a   Da Silva Meirelles, Lindolfo ^b   Fazan, Rubens ^a   Salgado, Helio Cesar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DETRENDED FLUCTUATION ANALYSIS; ELECTROCARDIOGRAPHY; ENTROPY; FEMORAL ARTERY; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART RATE VARIABILITY; HEART WEIGHT; LEFT CORONARY ARTERY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; ARRHYTHMIAS, CARDIAC; BIOLOGICAL THERAPY; CORONARY BLOOD VESSEL; CYTOLOGY; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RADIONUCLIDE VENTRICULOGRAPHY; SURGERY; WISTAR RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; ARTERIAL PRESSURE; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CELL- AND TISSUE-BASED THERAPY; CORONARY VESSELS; HEART FAILURE; HEART RATE; HEMODYNAMICS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RADIONUCLIDE VENTRICULOGRAPHY; RATS; RATS, WISTAR; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84940912991     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0573     Document Type: Article

References (53)

1. Felder RB, J Francis, RM Weiss, Z Zhang, S Wei and AK Johnson. (2001). Neurohumoral regulation in ischemiainduced heart failure. Role of the forebrain. Ann N Y Acad Sci 940:444-453.
2. Krieger EM, HC Salgado and LC Michelini. (1982). Resetting of baroreceptors. Int Rev Physiol 26:119-146.
3. Dibona GF and LL Sawin. (1994). Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol 266: R27-R39.
4. La Rovere MT, Bigger JT Jr, FI Marcus, A Mortara and PJ Schwartz. (1998). Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351:478-484.
5. Porter TR, DL Eckberg, JM Fritsch, RF Rea, LA Beightol, JF Schmedtje and PK Mohanty. (1990). Autonomic pathophysiology in heart failure patients: sympathetic-cholinergic interrelations. J Clin Invest 85:1362-1371.
6. Mark AL. (1995). Sympathetic dysregulation in heart failure: mechanisms and therapy. Clin Cardiol 18:I3-I8.
7. Olshsnsky B, HN Sabbah, PJ Hauptman and WS Colucci. (2008). Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863-871.
8. da Silva Meirelles L and NB Nardi. (2009). Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci 14:4281-4298.
9. Mazhari R and JM Hare. (2012). Translational findings from cardiovascular stem cell research. Trends Cardiovasc Med 22:1-6.
10. Madonna R, P Ferdinandy, R De Caterina, JT Willerson and AJ Marian. (2014). Recent developments in cardiovascular stem cells. Circ Res. 115:e71-e78.
11. Berry MF, AJ Engler, YJ Woo, TJ Pirolli, LT Bish, V Jayasankar, KJ Morine, TJ Gardner, DE Discher and HL Sweeney. (2006). Mesenchymal Stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290:H2196-H2203.
12. Davani S, A Marandin, N Mersin, B Royer, B Kantelip, P Herve, JP Etievent and JP Kantelip. (2003). Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108:II253-II258.
13. Nagaya N, K Kangawa, T Itoh, T Iwase, S Murakami, Y Miyahara, T Fujii, M Uematsu, H Ohgushi, et al. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:1128-1135.
14. Gnecchi M, H He, OD Liang, LG Melo, F Morello, H Mu, N Noiseux, L Zhang, RE Pratt, JS Ingwall and VJ Dzau. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368.
15. Pak HN, M Qayyum, Dt Kim, A Hamabe, Y Miyauchi, MC Lill, M Frantzen, K Takizawa, LS Chen, et al. (2003). Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 14:841-848.
16. Kim SK, HN Pak, JH Park, YF Fang, GI Kim, YD Park, C Hwang, YH Kim and BS Kim. (2010). Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart. Cardiol Young 20:308-317.
17. Wang Y, M Xue, Y-L Xuan, H-S Hu, W-J Cheng, F Suo, X-R Li, S-H Yan and L-X Wang. (2013). Mesenchymal stem cell therapy improves diabetic cardiac autonomic neuropathy and decreases the inducibility of ventricular arrhythmias. Heart Lung Circ 22:1018-1025.
18. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
19. Pfeffer MA, JM Pfeffer, MC Fishbein, PJ Fletcher, J Spadaro, RA Kloner and E Braunwald. (1979). Myocardial infarct size and ventricular function in rats. Cir Res 44:503-512.
20. Oliveira LF, J Mejia, EE Carvalho, RM Lataro, SN Frassetto, R Fazan Jr, HC Salgado, OY Galvis-Alonso and MV Simoes. (2013). Myocardial infarction area quantification using high-resolution SPECT images in rats. Arq Bras Cardiol 101:59-67.
21. Richman JS and JR Moorman. (2000). Physiological timeseries analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 278:H2039-H2049.
22. Peng CK, S Havlin, HE Stanley and AL Goldberger. (1995). Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time-series. Chaos 5:82-87.
23. Duque JJ, LEV Silva and LO Murta. (2013). Open architecture software platform for biomedical signal analysis. In: 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Osaka 2084-2087.
24. Task Force Of The European Society Of Cardiology. (1996). The North American Society Of Pacing Eletrophysiology: heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065.
25. Jugdutt BI. (2003). Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough? Circulation 108:1395-1403.
26. Murdoch CE, M Zhang, AC Cave and AM Shah. (2006). NADPH oxidase-dependent redox signaling in cardiac hypertrophy, remodeling and failure. Cardiovasc Res 71:208-215.
27. Meirelles L da S, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
28. Guarita-Souza LC, KA Carvalho, BR Simeone, JC Franscisco, N Miyague and M Olandoski. (2006). Functional outcome of bone marrow stem cells: mononuclear versus mesenchymal stem cell safer cellular therapy in myocardial scar in Wistar rats. Transplant Proc 38:1953-1954.
29. Amado LC, KH Schuleri, AP Saliaris, AJ Boyle, R Helm, B Oskouei, M Centola, V Eneboe, R Young, et al. (2006). Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48:2116-2124.
30. Cheng Z, X Liu, L Ou, X Zhou, Y Liu, X Jia, J Zhang, Y Li and D Kong. (2008). Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther 22: 363-371.
31. Osterziel KJ, D Hänlein, R Willenbrock, C Eichhorn, F Luft and R Dietz. (1995). Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73:517-522.
32. Li M, C Zheng, T Sato, T Kawada, M Sugimachi and K Sunagawa. (2004). Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109:120-124.
33. Du XJ, HS Cox, AM Dart and MD Esler. (1998). Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. J Cardiovasc Pharmacol 31:937-944.
34. Gao L, HD Schultz, KP Patel, IH Zucker and W Wang. (2005). Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 45:1173-1181.
35. Sabino JP, CA da Silva, H Giusti, ML Glass, Hc Salgado and R Fazan JR. (2013). Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats. Auton Neurosci 179:43-48.
36. Gheorghiade M,MVaduganathan, A Ambrosy,MBöhm, U Campia, JG Cleland, F Fedele, GC Fonarow, AP Maggioni, et al. (2013). Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev 18:107-122.
37. Sapoznikov D, R Backenroth and D Rubinger. (2010). Baroreflex sensitivity and sympatho-vagal balance during intradialytic hypotensive episodes. J Hypertens 28:314-324.
38. Kar S, L Gao, DA Belatti, Pl Curry and IH Zucker. (2011). Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 58:627-634.
39. Flora JS. (2009). Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54:375-385.
40. Eckberg DL, M Drabinsky and E Braunwald. (1971). Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285:877-883.
41. Nolan J, PD Batin, R Andrews, SJ Lindsay, P Brooksby, M Mullen, W Baig, AD Flapan, A Cowley, et al. (1998). Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure and Assessment of Risk Trial. Circulation 98:1510-1516.
42. Voss A, S Schulz, R Schroeder, M Baumert and P Caminal. (2009). Methods derived from nonlinear dynamics for analyzing heart rate variability. Philos Trans A Math Phys Eng Sci 367:277-296.
43. Pincus SM and AL Goldberger. (1994). Physiological timeseries analysis: what does regularity quantify? Am J Physiol 266:H1643-H1656.
44. Makikallio TH, HV Huikuri, U Hintze, J Videbaek, RD Mitrani, A Castellanos, RJ Myerburg and M Moller. (2001). DIAMOND Study Group (Danish Investigations of Arrhythmia and Mortality ON Dofetilide). Fractal analysis and time-and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 87:178-182.
45. Porta A, T Gnecchi-Ruscone, E Tobaldini, S Guzzetti, R Furlan and N Montano. (2007). Progressive decrease of heart period variability entropy-based complexity during graded head-up tilt. J Appl Physiol 103:1143-1149.
46. Huikuri HV, TH Makikallio, CK Peng, AL Goldberger, U Hintze and M Moller. (2000). Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 101:47-53.
47. Tapanainen JM, PE Thomsen, L Kober, C Torp-Pedersen, TH Makikallio, AM Still, KS Lindgren and HV Huikuri. (2002). Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 90:347-352.
48. Shake JG, PJ Gruber, WA Baumgartner, G Senechal, J Meyers, JM Redmond, MF Pittenger and BJ Martin. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 73:1919-1925.
49. Kocher AA, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards and S Itescu. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
50. Tomita S, RK Li, RD Weisel, DA Mickle, EJ Kim, T Sakai and ZQ Jia. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256.
51. Ortiz LA, F Gambelli, C Mcbride, D Gaupp, M Baddoo, N Kaminski and DG Phinney. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407-8411.
52. Azizi SA, D Stokes, BJ Augelli, C Digirolamo and DJ Prockop. (1998). Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci U S A 95:3908-3913.
53. Vrtovec B, G Poglajen and F Haddad. (2013). Stem cell therapy in patients with heart failure. Methodist Debakey Cardiovasc J 9:6-10.